default author photo

Michael Sebag

McGill University

1001 Sherbrooke St. W

Montreal

Canada

SCHOLARLY PAPERS

3

DOWNLOADS

117

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Covid-19 Vaccine Immunogenicity and Safety Surrounding Fourth and Subsequent Vaccine Doses in Patients with Hematologic Malignancies

Number of pages: 25 Posted: 12 Mar 2024
University of Toronto, University of Ottawa, University of Toronto, University of Toronto, McGill University, University of Alberta, University of Toronto, Queen's University, Jewish General Hospital, Montreal, McMaster University, Western University, University of Calgary, Saint John of God Hospital, University of British Columbia (UBC), University of British Columbia (UBC), University of Ottawa - Ottawa Hospital Research Institute, University of Ottawa, University of Ottawa - Ottawa Hospital Research Institute, University of Toronto, University of Ottawa, University of Ottawa and University of Ottawa
Downloads 57 (989,921)

Abstract:

Loading...

hematologic malignancies, COVID-19 vaccination, fourth and subsequent COVID-19 vaccines

2.

Real-World Outcomes in Myeloma Patients with T (11;14): A Matched Comparison Using the Canadian Myeloma Research Group National Clinical Database

Number of pages: 19 Posted: 07 Aug 2025
Vancouver General Hospital, BC Cancer - Vancouver, University of Western Ontario - London Health Sciences Centre, Princess Margaret Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Cross Cancer Institute, University of Calgary - Arnie Charbonneau Cancer Institute, McMaster University, Vancouver General Hospital, McMaster University, McGill University, affiliation not provided to SSRN, Saint John of God Hospital, CancerCare Manitoba, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 33 (1,277,121)

Abstract:

Loading...

myeloma, plasma cell dyscrasias, BCL2 inhibitor

3.

Salvage autologous stem cell transplantation outcomes in relapsed multiple myeloma: Real world evidence from the Canadian Myeloma Research Group Database

Number of pages: 37 Posted: 14 Sep 2025
affiliation not provided to SSRN, BC Cancer - Vancouver, Princess Margaret Hospital, University of British Columbia (UBC) - Faculty of Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, McMaster University, Cross Cancer Institute, University of Calgary - Arnie Charbonneau Cancer Institute, Vancouver General Hospital, McMaster University, University of Western Ontario - London Health Sciences Centre, McGill University, Saint John of God Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, CancerCare Manitoba, affiliation not provided to SSRN, University of Toronto - University Health Network, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 27 (1,359,097)

Abstract:

Loading...

Multiple myeloma, autologous stem cell transplantation, ASCT2, Maintenance Therapy